The post says baseline TSH, free T4, free T3 and TPO antibodies establish a thyroid-health snapshot before semaglutide initiation

Indications and Usage Wegovy (semaglutide) injection is indicated in combination with a reduced calorie diet and increased physical activity: To reduce the risk of major adverse cardiovascular (CV) events (CV death, non-fatal myocardial infarction, or non-fatal stroke) in adults with established CV disease and either obesity or overweight To reduce excess body weight and maintain weight reduction long term in: Adults and pediatric patients 12 years and older with obesity Adults with overweight in the presence of at least one weight-related comorbidity Wegovy (semaglutide) tablets are indicated in combination with a reduced calorie diet and increased physical activity to: Reduce the risk of major adverse cardiovascular (CV) events (CV death, non-fatal myocardial infarction, or non-fatal stroke) in adults with established CV disease and either obesity or overweight Reduce excess body weight and maintain weight reduction long term in adults with obesity or with overweight in the presence of at least one weight-related comorbidity Limitations of Use: Concomitant use of Wegovy tablets or Wegovy injection with other semaglutide-containing products or with any GLP-1 receptor agonist is not recommended

(2025) [6] investigated the effect of treatment with tirzepatide on HFpEF (Table 3)
The total cost of a proper storage setup is negligible compared to the cost of a single wasted vial
Maintenance Phase: Once the patients weight loss goals have been reached, they may receive an injection once or twice a month
Our approach incorporates prescription drugs like Semaglutide and Tirzepatide, proven to aid in weight management and help patients lose weight effectively